Monday, June 1, 2026RSS Feed
Rockford

Rockford Hospital Enrolls First U.S. Patient in Stroke Prevention Trial

MercyHealth's Javon Bea Hospital in Rockford enrolled the first U.S. patient in the INTERCEPT stroke prevention trial, a study that could change how doctors protect atrial fibrillation patients from future strokes.

DH
·2 min read

A First for Rockford Medicine

MercyHealth’s Javon Bea Hospital announced Friday that it enrolled the first U.S. patient in a major stroke prevention trial. The milestone puts Rockford at the center of a national effort to keep stroke patients from suffering another attack.

The trial is called INTERCEPT. It is sponsored by Javelin Medical and targets patients with atrial fibrillation who have already experienced a stroke.

How the Trial Works

Atrial fibrillation is an irregular heartbeat that causes blood clots to form in the heart. Those clots can travel to the brain through the carotid artery and trigger a stroke.

Vibhav Bansal, comprehensive stroke center director at Javon Bea Hospital, explained the approach.

“The intercept trial is looking at whether or not placing filters within the carotid artery to basically filter those clots out or filter those clots from getting up to the brain will actually prevent stroke,” Bansal said.

The procedure involves placing filters inside the carotid artery. The filters are designed to catch clots before they reach the brain.

Why It Matters for Rockford

Rockford residents with atrial fibrillation who have survived a stroke now have access to a treatment that has not been available to any other U.S. patient.

Hospital leaders describe the need as critical and unmet. Many patients with atrial fibrillation cannot take blood thinners due to bleeding risks or other medical conditions. The INTERCEPT trial offers an alternative path for those patients.

Bansal said the trial addresses a gap in stroke prevention that has persisted for years. The hospital’s stroke center is positioned to lead the research because of its experience treating complex stroke cases.

What Comes Next

The enrollment of the first U.S. patient marks the beginning of data collection. Results from the trial could change how doctors across the country prevent strokes in high-risk patients.

MercyHealth did not release the number of patients expected to participate in the trial. The hospital did not specify a timeline for when results would be available.

Rockford residents with questions about the trial can contact MercyHealth’s Javon Bea Hospital stroke center directly.

RockfordMercyHealthJavon Bea Hospitalstroke preventionINTERCEPT trialatrial fibrillationVibhav BansalJavelin Medicalclinical trial